Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$291K Sell
1,035
-110
-10% -$27.7K 0.07% 165
2026
Q1
$278K Sell
1,145
-30
-3% -$8.12K 0.06% 157
2025
Q4
$348K Sell
1,175
-26
-2% -$7.79K 0.09% 139
2025
Q3
$339K Hold
1,201
0.09% 143
2025
Q2
$354K Hold
1,201
0.1% 132
2025
Q1
$299K Buy
1,201
+258
+27% +$63.1K 0.08% 137
2024
Q4
$207K Hold
943
0.06% 153
2024
Q3
$208K Buy
+943
New +$185K 0.06% 147
2024
Q2
Sell
-1,084
Closed -$207K 150
2024
Q1
$207K Buy
+1,084
New +$198K 0.06% 139
2022
Q4
Sell
-3,021
Closed -$359K 155
2022
Q3
$359K Sell
3,021
-100
-3% -$13.1K 0.13% 96
2022
Q2
$441K Buy
3,121
+1,375
+79% +$186K 0.16% 95
2022
Q1
$227K Buy
1,746
+23
+1% +$3K 0.07% 153
2021
Q4
$236K Sell
1,723
-35
-2% -$4.39K 0.07% 138
2021
Q3
$234K Hold
1,758
0.08% 147
2021
Q2
$246K Buy
+1,758
New +$240K 0.08% 127
2019
Q4
Sell
-1,519
Closed -$208K 158
2019
Q3
$208K Sell
1,519
-4
-0.3% -$540 0.08% 104
2019
Q2
$201K Hold
1,523
0.08% 113
2019
Q1
$205K Buy
+1,523
New +$194K 0.08% 96
2018
Q4
Sell
-1,773
Closed -$256K 183
2018
Q3
$256K Buy
+1,773
New +$248K 0.11% 122

Other funds holding IBM

Doliver Advisors's IBM Position: Q2 2026 in Review

Doliver Advisors reduced its IBM (IBM) stake by 9.6% in Q2 2026, selling an estimated $27.7K and leaving 1,035 shares worth $291K. The position accounts for 0.07% of the portfolio, ranked #165.

Doliver Advisors first reported a position in IBM in Q3 2018 and has held it in 19 quarters since. The position peaked at $441K in Q2 2022. 1,124 funds tracked by Wall St. Rank hold IBM as of Q2 2026.

  • Doliver Advisors held 1,035 shares of IBM worth $291K as of Q2 2026.
  • Doliver Advisors sold 110 IBM shares in Q2 2026, an estimated $27.7K.
  • IBM made up 0.07% of Doliver Advisors's portfolio in Q2 2026, its #165 holding.
  • Doliver Advisors first reported a position in IBM in Q3 2018 and has held it in 19 quarters since.
  • Doliver Advisors's IBM position peaked at $441K in Q2 2022.
  • 1,124 funds tracked by Wall St. Rank held IBM as of Q2 2026.

Based on Doliver Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.